StonvexLoading…
StonvexStonvexStonvexCore line items from AVNS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $182.20M | $701.20M | $520.30M | $342.50M |
Operating Income | $8.90M | $-61.60M | $-64.10M | $-64.20M |
Net Income | $5.10M | $-72.90M | $-71.60M | $-70.20M |
EPS (Diluted) | $0.11 | $-1.57 | $-1.55 | $-1.52 |
Total Assets | $1.05B | $1.07B | $1.07B | $1.04B |
Total Liabilities | $268.00M | $295.50M | $289.70M | $262.70M |
Cash & Equivalents | $65.60M | $89.80M | $70.50M | $90.30M |
Free Cash Flow OCF − CapEx | $-16.60M | $43.10M | $21.80M | $14.80M |
Shares Outstanding | 46.67M | 46.46M | 46.42M | 46.31M |